Aug 24, 2026 07:35AM
May 14, 2026 07:31AM
May 14, 2026 07:30AM
May 13, 2026 07:30AM
May 13, 2026 07:30AM
May 12, 2026 07:30AM
May 12, 2026 07:30AM BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients
May 7, 2026 07:30AM
May 7, 2026 07:30AM
May 6, 2026 07:31AM
May 6, 2026 07:30AM
Jan 27, 2026 07:30AM
Jan 27, 2026 07:30AM
Nov 25, 2025 07:30AM BriaCell to present clinical data at breast cancer symposium
Nov 25, 2025 07:30AM
Oct 22, 2025 07:30AM
Oct 22, 2025 07:30AM
Oct 21, 2025 07:50AM
Oct 21, 2025 07:50AM
Oct 20, 2025 07:31AM
Oct 20, 2025 07:30AM BriaCell Presents Phase 3 Clinical Biomarker Data at ESMO 2025
Jul 31, 2025 07:30AM
Jul 31, 2025 07:30AM
Jul 2, 2025 07:31AM
Jul 2, 2025 07:30AM
Jun 24, 2025 07:38AM
Jun 24, 2025 07:30AM
May 23, 2025 07:42AM BriaCell Therapeutics (BCTX) Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025
May 23, 2025 07:30AM
Apr 23, 2025 06:39AM
Apr 22, 2025 07:31AM
Apr 22, 2025 07:30AM
Mar 20, 2025 08:02AM
Mar 20, 2025 08:00AM
Dec 2, 2024 07:50AM BriaCell Therapeutics (BCTX) Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer
Dec 2, 2024 07:50AM
Oct 15, 2024 07:51AM
Oct 15, 2024 07:50AM
Sep 19, 2024 06:41AM
Sep 10, 2024 07:51AM
Sep 10, 2024 07:50AM
Jun 27, 2023 08:06AM BriaCell Therapeutics (BCTX) Announces FDA Approval of Registrational Study Design
Jun 27, 2023 08:05AM
May 15, 2023 08:01AM
May 15, 2023 08:00AM
Feb 23, 2023 08:03AM
Feb 23, 2023 08:00AM
Jan 24, 2023 09:07AM
Jan 24, 2023 09:07AM BriaCell CEO Letter to Shareholders
Jan 18, 2023 08:48AM

330,175 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All